And our CEO is the perfect example.
More money for a new advisory board
Hired a new chief science officer this month
States topline results for the stem cell mobilization will be in 2017 however Washington state says top line results in 2023
Topline data from the BL8040 2a trial was to be presented in June and now will not be announced until an upcoming US conference, ASH December 2016?
Absolutely no communication skills and a non existing IR department.
If the 2 largest holders sell out as Broadfin did, the share price will be .30 before ASH
Less than 19,000 shares traded with half the trading gone
Where is Roth? We need a new $7.00 prediction..................What a efin joke
Possible bio marker identified and waiting on further conformation?
Overall this trial has 3 years of data to date
Ole Ech dropped out and didn't worry about time, thought we could heal with his mind
Not quite in line with the administration and function of multi scam
$1.85 Going into August before the PMDA decision, if the trial is not accepted by the PMDA, ATHX is a.40 stock over night
toxic blumper twin wants to be the toxicdumper! Though I too am unhappy with management, BL8040 is the golden fleece. 2.0 mg Dose gets the complete remission rate to 45% and some positive news with the length of remission get the attention of some pharma heavy weights at the 21st EHA congress, Roth may see their $7 dream
Next catalyst will be June 20th when the board and managements has shareholders vote on the incentive awards and renewal of board pukes
From memory surv, I don't remember you ever making a prediction until now? I put myself out there daily, BLRX will be huge this year, ATHX is in the $2.00 zone and no doubt will be trading in the $1.50 -$2.00 zone going into August